719 related articles for article (PubMed ID: 24259964)
1. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
2. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
Fousekis FS; Theopistos VI; Katsanos KH; Tsianos EV; Christodoulou DK
Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
[TBL] [Abstract][Full Text] [Related]
4. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
Navaneethan U; Shen B
Inflamm Bowel Dis; 2010 Sep; 16(9):1598-619. PubMed ID: 20198712
[TBL] [Abstract][Full Text] [Related]
5. Hepatic manifestations of inflammatory bowel diseases.
Restellini S; Chazouillères O; Frossard JL
Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
Silva J; Brito BS; Silva INN; Nóbrega VG; da Silva MCSM; Gomes HDN; Fortes FM; Pimentel AM; Mota J; Almeida N; Surlo VC; Lyra A; Rocha R; Santana GO
Biomed Res Int; 2019; 2019():7604939. PubMed ID: 30834274
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary manifestations of inflammatory bowel disease.
Yarur AJ; Czul F; Levy C
Inflamm Bowel Dis; 2014 Sep; 20(9):1655-67. PubMed ID: 24874461
[TBL] [Abstract][Full Text] [Related]
8. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
Seo KI; Kang SB
Korean J Gastroenterol; 2019 May; 73(5):248-259. PubMed ID: 31132831
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary manifestations of inflammatory bowel disease.
Raj V; Lichtenstein DR
Gastroenterol Clin North Am; 1999 Jun; 28(2):491-513. PubMed ID: 10372279
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.
Fousekis FS; Katsanos KH; Theopistos VI; Baltayiannis G; Kosmidou M; Glantzounis G; Christou L; Tsianos EV; Christodoulou DK
BMC Gastroenterol; 2019 Apr; 19(1):48. PubMed ID: 30943899
[TBL] [Abstract][Full Text] [Related]
11. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
Gizard E; Ford AC; Bronowicki JP; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2014 Jul; 40(1):3-15. PubMed ID: 24815622
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary disease in inflammatory bowel disease.
Ahmad J; Slivka A
Gastroenterol Clin North Am; 2002 Mar; 31(1):329-45. PubMed ID: 12122741
[TBL] [Abstract][Full Text] [Related]
14. [Hepatobiliary complications of idiopathic intestinal inflammations].
Lukás M
Cas Lek Cesk; 1997 Feb; 136(4):106-10. PubMed ID: 9221179
[TBL] [Abstract][Full Text] [Related]
15. Liver complications in inflammatory bowel diseases.
Wieser V; Gerner R; Moschen AR; Tilg H
Dig Dis; 2013; 31(2):233-8. PubMed ID: 24030232
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity of agents used in the management of inflammatory bowel disease.
Khokhar OS; Lewis JH
Dig Dis; 2010; 28(3):508-18. PubMed ID: 20926880
[TBL] [Abstract][Full Text] [Related]
17. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
Massironi S; Pirola L; Mulinacci G; Ciaccio A; Viganò C; Palermo A; Zilli A; Invernizzi P; Danese S
Inflamm Bowel Dis; 2023 Sep; 29(9):1477-1487. PubMed ID: 36040402
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Complications of Inflammatory Bowel Disease.
Mahfouz M; Martin P; Carrion AF
Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
[TBL] [Abstract][Full Text] [Related]
19. Current approach to hepatobiliary manifestations in inflammatory bowel disease.
Majchrzak K; Dudek P; Talar-Wojnarowska R; Fichna J
J Physiol Pharmacol; 2021 Oct; 72(5):. PubMed ID: 35158328
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
